COMPASS BIOINFORMATICS INC.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
InheriNext® is an AI-powered NGS analysis platform by Compass Bioinformatics, FDA Class I SaMD certified. Its modular design automates and streamlines the entire workflow—from sequencing data to clinical reporting—enabling fast, accurate, and standardized
The content above was translated by Ai
Founded Year
2015
Unified Business No.
24727426
Status
Active
Number of Employees
0
Total Paid-in
Capital
356,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Compass Bioinformatics is committed to becoming a global leader in Software as a Medical Device (SaMD) for multi-omics. We are a team of clinicians, AI data scientists, bioinformatics experts, and system developers across USA, Japan, and Taiwan.
The content above was translated by Ai
